Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Cannabinoid controlled release - InnoCan Pharma

Next Previous
Drug Profile

Cannabinoid controlled release - InnoCan Pharma

Alternative Names: Cannabinoid loaded liposomes - Innocan Pharma ; LPT-CBD

Latest Information Update: 21 May 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Hebrew University of Jerusalem
  • Class Analgesics; Antiepileptic drugs; Cannabinoids
  • Mechanism of Action Cannabinoid receptor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Epilepsy; Pain

Most Recent Events

  • 06 May 2025 InnoCan Pharma receives notice of allowance for patent covering its proprietary topical pain-relief technology in Mexico
  • 07 Apr 2025 InnoCan Pharma files for patent protection for liposome-based CBD technology in China
  • 18 Feb 2025 Innocan Pharma has a patent protection in India covering a prolonged-release pharmaceutical formulation, utilizing liposomes to encapsulate cannabinoids

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top